Protection against Tuberculosis with Homologous or Heterologous Protein/Vector Vaccine Approaches Is Not Dependent on CD8+ T Cells-Reference-Cited by-同舟云学术

Protection against Tuberculosis with Homologous or Heterologous Protein/Vector Vaccine Approaches Is Not Dependent on CD8+ T Cells

Published:2013-07-31 Issue:5 Volume:191 Page:2514-2525
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Baldwin Susan L.,Ching Lance K.,Pine Samuel O.,Moutaftsi Magdalini,Lucas Elyse,Vallur Aarthy,Orr Mark T.,Bertholet Sylvie,Reed Steven G.,Coler Rhea N.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Tuberculosis: a global overview of the situation today.;Sudre;Bull. World Health Organ.,1992

2. WHO . 2012. Global Tuberculosis Report 2012. World Health Organization, Geneva.

3. The success and failure of BCG — implications for a novel tuberculosis vaccine

4. Identification of Human T Cell Antigens for the Development of Vaccines againstMycobacterium tuberculosis

5. A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis;Vaccines;2023-01-05

2. Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen;Tuberculosis;2023-01

3. A novel peptide vaccination augments cytotoxic CD8+ T-cell responses against Mycobacterium tuberculosis HspX antigen;Immunobiology;2022-05

4. It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity;Frontiers in Immunology;2022-03-10

5. RNA-based vaccine demonstrates prophylactic efficacy against Mycobacterium tuberculosis challenge in a mouse model;2022-02-24